Pharmaceutical Components at Risk for Melamine Contamination: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 6, 2009
May 15, 2020
b67e8a1e-249f-4a0f-b5e4-4c87ca550b18
Related Documents
Process Validation: General Principles and Practices: Guidance for Industry
Guidance DocumentJanuary 25, 2011Center for Drug Evaluation and Research
Heparin for Drug and Medical Device Use: Monitoring Crude Heparin for Quality: Guidance for Industry
Guidance DocumentJune 25, 2013Center for Drug Evaluation and Research
Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination: Guidance for Industry
Guidance DocumentApril 17, 2013Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.